Literature DB >> 1465576

Septic shock induced by group A streptococcal infection: clinical and therapeutic aspects.

B Stegmayr1, S Björck, S Holm, J Nisell, A Rydvall, B Settergren.   

Abstract

During 1988 and 1989 > 500 cases of serious group A streptococcal infections were reported in Sweden, many with a fatal outcome. We report here on 11 consecutive patients with septic preshock/shock and multiorgan failure, including acute renal failure. 10 had verified group A streptococci (GAS) serotype T1M1 infections while 1 patient was culture negative but with clinical signs of severe infection and serological evidence of GAS infection. Presenting symptoms were high fever, relative bradycardia, edema and renal failure. In all patients the condition deteriorated despite conventional treatment including volume substitution and antibiotics. Systolic blood pressure was transiently < 80 mmHg in 10 patients and 9 of them needed infusion of inotropic agents to avoid fatal circulatory shock. In 9 patients respiratory aid was instituted and 7 were dialysed. Plasma exchange was performed in 7, while the remaining 4 received transfusions with blood and plasma without plasma exchange. 10 patients improved and were discharged within 8 weeks. One woman died within 2 days after admission to the hospital. Renal function recovered in all survivors, with a follow-up serum creatinine < 80 mumol/l. The complicated clinical picture in these patients with many simultaneous therapeutic events confounds the interpretation of the effect of single actions. The favourable outcome in these severely ill patients suggests that potent inotropic agents, immunoglobulin therapy and plasma exchange might be beneficial in severe streptococcal disease when conventional treatment fails.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1465576     DOI: 10.3109/00365549209054644

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  13 in total

1.  Therapeutic Approaches to Streptococcal Toxic Shock Syndrome.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

Review 2.  Back to the future: antibody-based strategies for the treatment of infectious diseases.

Authors:  H Barbaros Oral; Cüneyt Ozakin; Cezmi A Akdiş
Journal:  Mol Biotechnol       Date:  2002-07       Impact factor: 2.695

3.  Successful treatment of severe streptococcal toxic shock syndrome with a combination of intravenous immunoglobulin, dexamethasone and antibiotics.

Authors:  C H Chiu; J T Ou; K S Chang; T Y Lin
Journal:  Infection       Date:  1997 Jan-Feb       Impact factor: 3.553

4.  Toxic shock syndrome due to group C streptococci. A case report.

Authors:  S Natoli; C Fimiani; N Faglieri; L Laurenzi; A Calamaro; A M Frasca; E Arcuri
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

5.  Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections.

Authors:  H Basma; A Norrby-Teglund; A McGeer; D E Low; O El-Ahmedy; J B Dale; B Schwartz; M Kotb
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 6.  Streptococcal toxic shock syndrome in a postpartum woman. Case report and review of the literature.

Authors:  C Jorup-Rönström; M Hofling; C Lundberg; S Holm
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

Review 7.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

8.  The Treatment of Severe Group A Streptococcal Infections.

Authors:  Anna Norrby-Teglund; S. Ragnar Norrby; Donald E. Low
Journal:  Curr Infect Dis Rep       Date:  2003-02       Impact factor: 3.725

9.  Maternal death following epidural anaesthesia for caesarean section delivery in a patient with unsuspected sepsis.

Authors:  P J Morgan
Journal:  Can J Anaesth       Date:  1995-04       Impact factor: 5.063

Review 10.  Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment.

Authors:  D L Stevens
Journal:  Emerg Infect Dis       Date:  1995 Jul-Sep       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.